Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 12, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Impella 5.5 insertion: step by step.

Fiamma Furiasse1, Elena Roselló-Díez1, Sandra Casellas1

  • 1Department of Cardiac Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Multimedia Manual of Cardiothoracic Surgery : MMCTS
|July 10, 2026
PubMed
Summary

This case study highlights the successful use of the Impella 5.5 heart pump in a patient experiencing severe left ventricular dysfunction following ST elevation myocardial infarction. The advanced mechanical circulatory support facilitated recovery and improved heart function before discharge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right Ventricular Mechanical Support With ProtekDuo Cannula as a Bridge to Recovery After Post-Infarction Ventricular Septal Defect Repair.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Surgical Versus Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: 1-Year Clinical Outcomes in Patients Aged 65 Years and Older.

Journal of the American Heart Association·2026
Same author

Postcardiotomy veno-arterial membrane oxygenation as a bridge to heart replacement therapies.

Heart & lung : the journal of critical care·2026
Same author

Treatment-Resistant Atopic Dermatitis in Adulthood: A Case Report.

Cureus·2025
Same author

Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?

The Canadian journal of cardiology·2025
Same author

Intravenous Iron Therapy in Patients Admitted With Acute Heart Failure and Iron Deficiency: A Systematic Review and Meta-Analysis.

Cureus·2025

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Devices

Background:

  • ST elevation myocardial infarction (STEMI) can lead to severe left ventricular dysfunction.
  • Hemodynamic instability in STEMI patients often necessitates advanced mechanical circulatory support.
  • Complex coronary artery disease, including multiple chronic occlusions, presents significant management challenges.

Purpose of the Study:

  • To describe the successful implantation and management of an Impella 5.5 device in a patient with STEMI and severe left ventricular dysfunction.
  • To evaluate the efficacy of the Impella 5.5 as a bridge to recovery in a hemodynamically unstable patient.
  • To report on the clinical outcomes, including hemodynamic improvement and device explantation.

Main Methods:

  • A 56-year-old patient with STEMI and severe left ventricular dysfunction underwent urgent percutaneous coronary intervention with Impella CP support.
Keywords:
Axillary arteryHeart-assist device

Related Experiment Videos

Last Updated: Jul 12, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

  • Due to persistent hemodynamic instability, a transaxillary Impella 5.5 device was implanted.
  • The implantation involved surgical access via the right axillary artery and device placement under fluoroscopic and echocardiographic guidance.
  • Inotropic support was gradually withdrawn during Impella 5.5 therapy.

    • Main Results:

    • Successful implantation of the Impella 5.5 device was achieved.
    • The patient's hemodynamic status stabilized, allowing for gradual weaning from inotropic agents.
    • The Impella 5.5 device was successfully explanted after one week of support.
    • Significant improvement in left ventricular ejection fraction was observed prior to hospital discharge.

    Conclusions:

    • The Impella 5.5 provides effective mechanical circulatory support for patients with STEMI and severe left ventricular dysfunction.
    • Transaxillary Impella 5.5 implantation is a viable option for managing complex cases with hemodynamic instability.
    • This approach can facilitate myocardial recovery and improve patient outcomes, enabling device explantation and discharge.